What Cambridge Angels group does

Cambridge Angels is a UK business angel network founded in 2001 by Robert Sansom and David Cleevely, operating as Cambridge Angels Group Limited out of the Cambridge/Silicon Fen ecosystem with a registered office in Oakham, England and Wales. The group is an invitation-only membership network capped at 65 individual members, the large majority of whom are exited entrepreneurs in technology and healthcare, complemented by six corporate members from venture capital (ACF Investors, Albion VC, Amadeus Capital Partners, Martlet, Parkwalk Advisors, Playfair Capital) and Cambridge Enterprise. Governance is provided by co-chairs Amy Weatherup and Robert Swann, a board of ~13 members, and a small professional team led since October 2025 by CEO Emmi Nicholl, with Charlotte Kirby in management.

The group's core offering is curated early-stage equity investment in UK-registered companies, typically the first equity round, with ticket sizes of £150k-£1.5m per company and a stated target return of 10x initial investment within 5-10 years. Investment criteria focus on science/engineering-based or IP-rich technology and healthcare-enabling tools targeting B2B markets with a £100m+ opportunity. Since inception the network has deployed £150m+ into more than 120-150 portfolio companies spanning mental health technology (Augmentive.io), energy management (xWatts), medical devices (Microneedle Solutions, MNS, Orthofuse), battery technology (Illumion), and pest control technology (Spotta). Internally, Cambridge Angels uses AI-assisted screening of pitch decks to triage deal flow before member pitching sessions, and processes were reformed in 2024 to shorten the investment cycle. An Emeritus membership category was introduced in 2024 to formalise alumni retention.

Cambridge Angels operates as a non-profit-style group and is unregulated by the UK Financial Conduct Authority. It charges no pitching, due diligence, or carry fees to portfolio companies, and its operational costs are funded by membership fees from individual members plus corporate sponsorship, with HSBC Innovation Banking serving as the network's principal supporter. Distribution to entrepreneurs runs through a top-of-funnel mix of website content, LinkedIn, published portfolio and angel interviews, free office-hours feedback sessions, and regular pitching sessions; distribution to investors is referral-based through the invitation-only membership process.

Name

Cambridge Angels group

Legal name

Cambridge Angels Group Limited

Website

http://cambridgeangels.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

51–100 employees

Short description

Cambridge Angels is a UK business angel network founded in 2001 that provides smart capital from exited entrepreneurs to early-stage technology and healthcare companies. With up to 65 invitation-only members plus six corporate VC partners, the group invests £150k-£1.5m per company and has backed over 150 portfolio companies.

Ownership category

akta.pro rank

Product category

Angel Investment / Early-Stage Venture Capital

NAICS

Portfolio Management and Investment Advice (52394), Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro primary industry

Micro-VC & Angel Funds (FSANAAAI)

Keywords

• Angel investment network
• Early-stage equity funding
• Seed venture capital
• Business angel network
• Startup growth mentorship

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Membership fees and sponsorship: Cambridge Angels' costs are funded through membership fees and sponsorship. No charges are levied on companies seeking investment, nor do they charge pitching or 'carry' fees.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

Cambridge Angels is an invitation-only business angel network that pools capital from up to 65 high-net-worth members (predominantly exited entrepreneurs) to invest £150k–£1.5m equity rounds into early-stage UK technology and healthcare companies. It additionally provides portfolio support through mentorship, office hours, pitching sessions, and ecosystem networking, without charging any pitching, due diligence, or carry fees to investee companies.

Product overview

Cambridge Angels is a UK business angel network founded in 2001, providing smart capital from exited entrepreneurs to early-stage technology and healthcare companies. The organization offers investment services, mentorship, networking opportunities, and portfolio support rather than a traditional technology product. Services include curated deal flow for investors, access to experienced entrepreneurs as mentors, office hours for feedback, pitch sessions, and an investment criteria framework covering management teams, funding requirements (£150k-£1.5m), technology focus (science/engineering-based or IP-rich), B2B markets, and exit strategies.

Differentiator

Problem solved

Functional benefit

Products and services

• Seed and Series A Angel Investment Equity investment of typically £150k–£1.5m per company, usually the first equity round, into UK-registered early-stage technology and healthcare companies with credible teams, IP-rich or science/engineering-based propositions, and B2B markets. Members invest individually with the option (not obligation) to participate in any given round.
• Investor Membership Invitation-only membership for high-net-worth individuals (capped at 65) plus several corporate VC members, granting access to curated deal flow, co-investment opportunities, and the Cambridge Angels peer network. Membership is funded by recurring annual fees.
• Office Hours for Entrepreneurs Free, one-on-one, no-obligation feedback sessions for entrepreneurs from experienced Cambridge Angels investor members, used as a top-of-funnel engagement and pre-screening touchpoint.
• Pitching Sessions Regular pitching sessions to which screened companies meeting Cambridge Angels' investment criteria (UK-registered, science/engineering or IP-rich, B2B, £100m+ market, 10x exit path) are invited to present to the full membership.
• Portfolio Company Mentorship and Network Access Ongoing post-investment support for portfolio companies, including introductions to customer and partner networks, strategic advisory from exited entrepreneur members, and access to a peer community of fellow portfolio companies.
• Follow-on Capital Access via Corporate VC Members Pathway for portfolio companies to access later-stage venture capital through Cambridge Angels' six corporate VC members (ACF Investors, Albion VC, Amadeus Capital Partners, Martlet, Parkwalk Advisors, Playfair Capital) and Cambridge Enterprise.

Quantifiable outcome

• Over £150m invested in 120+ portfolio companies since 2001
• +2 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Emmi Nicholl Promotion to CEOcoreOthers · 23 October 2025Emmi Nicholl was promoted to CEO of Cambridge Angels, overseeing the group's activities, screening investment opportunities, and facilitating pitching and support events.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Crowdcube: UK equity crowdfunding platform enabling retail and HNW investors to back early-stage companies. Competes with Cambridge Angels for UK seed-stage deal flow and is increasingly used by founders seeking faster, broader capital raises with marketing benefits.
• Connect Ventures: London-based early-stage venture fund investing in European technology companies at seed and pre-seed. Comparable in early-stage UK technology focus but operates via institutional fund structure rather than angel syndication.
• Amadeus Capital Partners: UK deep-tech venture capital firm and corporate member of Cambridge Angels. Provides later-stage capital to portfolio companies and overlaps in thesis (technology-rich, IP-heavy UK companies) but operates at Series A and beyond rather than seed — making it both a partner and a broader incumbent.
• Octopus Ventures: UK venture arm of Octopus Group investing across seed to growth stages in UK and European technology companies. Comparable as a UK-based investor targeting early-stage B2B technology with similar sector breadth but materially larger cheque sizes.
• Albion VC: UK early-stage venture capital firm and corporate member of Cambridge Angels. Compares as an institutional early-stage investor into UK technology and healthcare, with a similar sector focus but operating through larger fund vehicles rather than an angel syndicate.

Emerging players

• SeedLegals: UK startup funding and legal infrastructure platform that streamlines fundraising, cap tables, and SEIS/EIS administration. Comparable as part of the broader UK seed-funding ecosystem that Cambridge Angels operates in, though focused on tooling rather than direct investment.

Direct peers

• SyndicateRoom: UK angel-led investment platform/network that co-invests alongside lead angels into early-stage UK companies. Comparable in target market (UK seed-stage companies), investor base (HNW individuals), and value proposition (curated deal flow plus syndicate structure).
• Parkwalk Advisors: UK investment firm specialising in university spin-out and IP-rich technology investments. Parkwalk is a corporate member of Cambridge Angels but also operates its own funds targeting a very similar thesis, making it a close functional peer in the Cambridge deep-tech ecosystem.
• Oxford Investment Opportunity Network (OION): UK university-region angel network based in Oxford with a structurally similar model — pooling HNW investors (often exited operators) to invest in early-stage UK companies. Directly comparable to Cambridge Angels as a fellow 'Oxbridge-adjacent' angel network targeting IP-rich spin-outs and B2B startups.
• Angel Investment Network: UK-headquartered online platform connecting angel investors with early-stage companies seeking funding. Comparable as a curated deal flow intermediary for HNW investors investing into UK startups, though with a broader geographic mandate than Cambridge Angels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/cambridge-angels

Revenue estimate

Valuation estimate

Number of profiles

Profiles16 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments136 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cambridge Angels group